Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
04/18/2017 04/19/2017 04/20/2017 04/21/2017 04/24/2017 Date
2630.05(c) 2635(c) 2600.05(c) 2585(c) 2570 Last
13 383 25 105 5 611 6 379 9 464 Volume
-1.27% +0.19% -1.33% -0.58% -0.58% Change
More quotes
Financials ( INR)
Sales 2017 29 474 M
EBIT 2017 4 275 M
Net income 2017 3 382 M
Finance 2017 7 632 M
Yield 2017 2,08%
Sales 2018 33 188 M
EBIT 2018 6 118 M
Net income 2018 4 603 M
Finance 2018 3 646 M
Yield 2018 2,21%
P/E ratio 2017 65,34
P/E ratio 2018 47,72
EV / Sales2017 7,19x
EV / Sales2018 6,50x
Capitalization 219 406 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
05/31Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
04/21 AKD Securities Limited Equity Research - Trigger Shark
04/18 GLAXOSMITHKLINE : Glaxo Submits New Drug Application For Shingles Vaccine In Jap..
03/31 GLAXOSMITHKLINE : Starts Phase III Study Of Mepolizumab
03/26 GLAXOSMITHKLINE PHARMACEUTICALS : Trailing twelve month results - glaxosmithklin..
03/26 GLAXOSMITHKLINE PHARMACEUTICALS : Quarterly results - glaxosmithkline pharmaceut..
03/15 GLAXOSMITHKLINE : Submits US Application To Expand Fluarix Indication
03/06 GLAXOSMITHKLINE : Reports Positive Phase IIIb Study Data For Nucala
02/23 GLAXOSMITHKLINE : Glaxo Gets Positive Headline Results On Relvar-Ellipta Asthma ..
02/17 GLAXOSMITHKLINE PHARMACEUTICALS : AKD Securities Limited Equity Research - Trigg..
02/16 Vectura Hits GBP9 Million Royalty Cap Under Skyepharma Legacy Deal
More news
Sector news : Pharmaceuticals - NEC
03:01a Becton Dickinson to acquire Bard for $24 billion
04/22DJNOVARTIS : Tests New Alzheimer's Drug on People Who Don't Have the Disease
04/21DJFDA OKs Samsung Bioepis's biosimilar version of J&J's Remicade
04/21 Teva's new asthma inhaler poses first competition for GSK's Advair
04/19DJSHIRE : Files 8K - Other Events
More sector news : Pharmaceuticals - NEC
Latest Tweets
04/23Nigerian researchers win GSK’s Open Lab Research Grants: GlaxoSmithKline Phar.. 
2016#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Apr 2016 growth p.. 
2015#Indian #stocks: #Merger #Acquisition: Glaxosmithkline Pharmaceuticals : spar.. 
2015#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Sep 2015 growth p.. 
2015#IndiaBombay #stocks: #Merger #Acquisition: Glaxosmithkline Pharmaceuticals :.. 
More tweets
Qtime:5
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 2 711  INR
Spread / Average Target 4,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
D. Sundaram Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMA..-5.31%3 395
JOHNSON & JOHNSON5.69%330 078
ROCHE HOLDING LTD.8.21%217 624
PFIZER INC.3.57%200 330
NOVARTIS AG-1.08%192 857
MERCK & CO., INC.5.13%169 673
More Results